Even modest post-infection complications can make expanded vaccine coverage cost-effective, modeling suggests

New modeling led by interdisciplinary scientists at the University of British Columbia (UBC) could help public health officials better factor in the long-term impacts of infectious disease when determining optimal vaccine coverage rates.

≈